ArticleAesthetic surgery journal. Open forum2026
Optimizing Nonablative Fractional Laser Treatment: Clinical Evaluation of a Novel 3-Dimentional Controlled Chaos Technology.
Article in Aesthetic surgery journal. Open forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 1550 nm nonablative fractional laser (NAFL) is a well-established and versatile technology in aesthetic dermatology, offering a minimally invasive solution for improvements in skin quality. In this study, the authors introduce a novel NAFL, MOSAIC 3-Dimensional Controlled Chaos Technology (3D CCT), engineered to enhance treatment efficacy and safety. The aim of the authors of this report is to evaluate the safety and efficacy of MOSAIC 3D CCT for facial rejuvenation using patient-reported outcomes, blinded expert assessments, and objective imaging analyses. A retrospective analysis was conducted on 14 patients, aged 34 to 73 years, with Fitzpatrick skin phototypes II to V, who underwent 3 sessions of NAFL treatment for facial rejuvenation at 1- to 2-month intervals. Outcomes were evaluated using the Scientific Assessment Scale of Skin Quality (SASSQ), quantitative analysis with LifeViz imaging software, and the FACE-Q questionnaire. SASSQ analysis showed a trend toward improvement, though none of the changes reached statistical significance (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.